Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Actin dependent CD95 internalization is specific for Type I cells.

Alicia Algeciras-Schimnich1, Marcus E Peter

  • 1The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th Street, Chicago, IL 60637, USA.

FEBS Letters
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a pan cancer therapy based on DISE-inducing short RNAs.

Molecular therapy. Nucleic acids·2026
Same author

Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio.

JAMA neurology·2026
Same author

Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Whole-proteome phage immunoprecipitation sequencing reveals germ cell tumor-specific immunosignature.

Nature communications·2026
Same author

Current State and Needs of Clinical Laboratories in Latin America: A Cross-Country Assessment.

The journal of applied laboratory medicine·2026
Same author

An automated plasma-based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit.

FEBS letters·2026
Same journal

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

FEBS letters·2026
Same journal

Decoding the dynamic extracellular matrix in cancer-3D models and bioscaffolds rewire the rules of tumor progression.

FEBS letters·2026
Same journal

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
Same journal

α-Synuclein aggregation landscape from phase separation to neurotoxic intermediates.

FEBS letters·2026
Same journal

Modelling stem cell differentiation related processes-A practical overview for biologists.

FEBS letters·2026
See all related articles

Type I and Type II cells exhibit distinct apoptosis pathways. CD95 internalization relies on actin in Type I cells, and both cell types differ in their active caspase-8 thresholds for apoptosis execution.

Area of Science:

  • Cell biology
  • Molecular biology
  • Immunology

Background:

  • Apoptosis, or programmed cell death, is crucial for development and homeostasis.
  • CD95 (also known as Fas receptor) is a key mediator of apoptosis.
  • Two distinct signaling pathways, Type I and Type II, are involved in CD95-mediated apoptosis, differing in their reliance on mitochondria.

Purpose of the Study:

  • To investigate the differences in CD95 internalization and caspase-8 activation thresholds between Type I and Type II cells.
  • To elucidate the role of the cytoskeleton in CD95-mediated apoptosis in these two cell types.

Main Methods:

  • Cellular assays to compare CD95 internalization mechanisms.
  • Biochemical analyses to quantify active caspase-8 levels.
  • Cytoskeletal disruption experiments.

Related Experiment Videos

Main Results:

  • CD95 internalization was found to be actin-dependent exclusively in Type I cells.
  • Type I and Type II cells demonstrated different thresholds of active caspase-8 required for apoptosis execution.
  • Evidence suggests differential CD95-cytoskeleton interactions in Type I and Type II cells.

Conclusions:

  • The distinct mechanisms of CD95 internalization and caspase-8 activation highlight cell-type-specific adaptations in apoptosis signaling.
  • Cytoskeletal linkage to CD95 influences apoptosis execution differently in Type I and Type II cells.
  • These findings provide insights into the regulation of programmed cell death via the CD95 pathway.